In the BioHarmony Drug Report Database

"Preview" Icon

Nitisinone

Nityr, Orfadin (nitisinone) is a small molecule pharmaceutical. Nitisinone was first approved as Nityr on 2002-01-18. It is used to treat tyrosinemias in the USA. It has been approved in Europe to treat tyrosinemias. The pharmaceutical is active against 4-hydroxyphenylpyruvate dioxygenase. Orfadin’s patents are valid until 2035-01-05 (FDA).

 

Trade Name

 

Orfadin
 

Common Name

 

nitisinone
 

ChEMBL ID

 

CHEMBL1337
 

Indication

 

tyrosinemias
 

Drug Class

 

Image (chem structure or protein)

Nitisinone structure rendering